NCT04941118

Myofascial Pain Syndrome and Dextrose Prolotherapy

Evaluation of the Effect of Dextrose Prolotherapy on Pain and Function in Women With Myofascial Pain Syndrome

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Mustafa Kemal University · Academic / Other
• Sex: Female
• Age: 20 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

Myofascial pain syndrome is characterized by the presence of hypersensitive points called trigger points that cause pain, tenderness, spasm, stiffness, limitation of movement, weakness, taut band within the muscle, and pain reflected by pressing in a muscle group or a single muscle. Prolotherapy is a regenerative treatment method in the treatment of chronic musculoskeletal pain, in which an irritating solution is injected, often hypertonic dextrose, into painful ligament and tendon attachments and adjacent joint spaces. In this study, it was aimed to examine the effect of prolotherapy application on pain, neck range of motion and neck disability in women with myofascial pain syndrome.

Conditions

• Efficacy of Dextrose Prolotherapy in Myofascial Pain Syndrome

Interventions

Type	Name	Description
DRUG	Injection of dextrose, local anesthetic and saline to the myofascial trigger point	An injection of 5 ml of 5% dextrose prolotherapy using 2.5 ml 10% dextrose, 1 ml 2% local anesthetic (lidocaine), 1.5 ml 0.9% saline will be administered to the active group from at least 10 trigger points.
DRUG	Local anesthetic and saline injection to the myofascial trigger point	A total of 5 ml of solution created by using 4 ml of 0.9% saline and 1 ml of 2% local anesthetic (lidocaine) will be administered to the control group, with at least 10 trigger points.

Timeline

• Start date: 2021-07-15
• Primary completion: 2021-12-30
• Completion: 2021-12-31
• First posted: 2021-06-28
• Last updated: 2021-07-21

Locations

1 site across 1 country: Turkey (Türkiye)